749 related articles for article (PubMed ID: 12814332)
1. Treatment of psychosis in Parkinson's disease: safety considerations.
Fernandez HH; Trieschmann ME; Friedman JH
Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Friedman JH; Factor SA
Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
Zahodne LB; Fernandez HH
Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
[TBL] [Abstract][Full Text] [Related]
4. Parkinson disease psychosis: Update.
Friedman JH
Behav Neurol; 2013 Jan; 27(4):469-77. PubMed ID: 23242358
[TBL] [Abstract][Full Text] [Related]
5. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for psychosis in Parkinson's disease patients.
Friedman JH
Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
Friedman JH
J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
[TBL] [Abstract][Full Text] [Related]
8. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
9. Current Understanding of Psychosis in Parkinson's Disease.
Ojo OO; Fernandez HH
Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
[TBL] [Abstract][Full Text] [Related]
10. Psychosis in Parkinson's disease: therapeutic options.
Hasnain M
Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
[TBL] [Abstract][Full Text] [Related]
11. Effects of newer antipsychotics on extrapyramidal function.
Tarsy D; Baldessarini RJ; Tarazi FI
CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
[TBL] [Abstract][Full Text] [Related]
12. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
Drach LM
Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach.
Friedman JH
Expert Opin Pharmacother; 2024 Feb; 25(2):149-156. PubMed ID: 38344806
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for depression and psychosis in Parkinson's disease.
Poewe W; Seppi K
J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
[TBL] [Abstract][Full Text] [Related]
15. Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson's Disease Psychosis: Systematic Review and Network Meta-Analysis.
Yunusa I; Rashid N; Seyedin R; Paratane D; Rajagopalan K
J Geriatr Psychiatry Neurol; 2023 Sep; 36(5):417-432. PubMed ID: 36720473
[TBL] [Abstract][Full Text] [Related]
16. Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
Iketani R; Kawasaki Y; Yamada H
Biol Pharm Bull; 2017; 40(11):1976-1982. PubMed ID: 29093347
[TBL] [Abstract][Full Text] [Related]
17. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine.
Abdul-Rahman T; Herrera-Calderón RE; Aderinto N; Kundu M; Wireko AA; Adebusoye FT; Ekerin O; Lawal L; Mykolaivna NI; Alexiou A; Almashjary MN; Perveen A; Ashraf GM
J Integr Neurosci; 2024 Apr; 23(4):80. PubMed ID: 38682215
[TBL] [Abstract][Full Text] [Related]
18. Management of psychosis in Parkinson's disease.
D'Souza C; Gupta A; Alldrick MD; Sastry BS
Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease psychosis 2010: a review article.
Friedman JH
Parkinsonism Relat Disord; 2010 Nov; 16(9):553-60. PubMed ID: 20538500
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
Molho ES; Factor SA
Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]